Armata Pharmaceuticals Inc. (ARMP)
NYSE
Real-time Data
01:30 PM
Day's Range
4.4252 wk Range
2.40Overview - ARMP - Armata Pharmaceuticals Inc.
Key Statistics
Valuation
Enterprise Value
479.62M
P/E (Trailing)
‪-1.03‬
P/E (Forward)
‪-3.24‬
PEG Ratio
‪-0.00062‬
Price / Sales (TTM)
‪34.21‬
Price / Book
‪-0.58‬
EV / EBITDA
‪-14.34‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪-410.83%‬
Return on Assets
‪-25.83%‬
Return on Equity
‪79.50%‬
Ownership
Shares Outstanding
36.64M
Float
11.90M
Short % of Shares Outstanding
‪7.94%‬
Held by Insiders
‪67.63%‬
Held by Institutions
‪13.45%‬
Price stats
Beta
‪1.32‬
50-Day Avg
‪5.34‬
200-Day Avg
‪7.55‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
2 analysts
Average price target
‪$ 17.50‬Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ARMP - Armata Pharmaceuticals Inc.
Peers - ARMP - Armata Pharmaceuticals Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NYSE.
- ARMPNYSEArmata Pharmaceuticals Inc.189.62MMarket Cap+47.63%52-week change-1.03P/E (Trailing)‪0.00%‬Profit Margin
- BIONYSEBio-Rad Laboratories Inc.10.16BMarket Cap+21.75%52-week change46.50P/E (Trailing)‪8.58%‬Profit Margin
- BHVNNYSEBiohaven Ltd.2.09BMarket Cap-7.95%52-week change-2.01P/E (Trailing)‪0.00%‬Profit Margin
- BSTNYSEBlackRock Science and Technology Trust1.72BMarket Cap+20.82%52-week change6.90P/E (Trailing)‪0.00%‬Profit Margin
- ANRONYSEAlto Neuroscience Inc.1.34BMarket Cap+88.51%52-week change-15.62P/E (Trailing)‪0.00%‬Profit Margin
- BCXNYSEBlackRock Resources & Commodities Strategy Trust1.00BMarket Cap+25.40%52-week change4.72P/E (Trailing)‪0.00%‬Profit Margin
- ATTONYSEAttovia Therapeutics Inc.895.00MMarket Cap-5.29%52-week change-8.78P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - ARMP - Armata Pharmaceuticals Inc.
About
Armata Pharmaceuticals Inc. is a biotechnology company dedicated to the development of innovative therapies to treat antibiotic-resistant infections. Operating in the healthcare sector, the company focuses on bacteriophage-based solutions, aiming to address the growing global issue of antimicrobial resistance. Armata…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
